Peru balsam ointment 6% w/w
CGR-ES-077 · FN/2006/PO/041 POMADA DE BÁLSAMO DE PERÚ
Documented bibliographic addition; requires local scientific approval before use as a master formulation record.
Source formula
| Ingredient | Source quantity |
|---|---|
| Peru balsam | 6 g |
| Virgin castor oil | 6 g |
| White beeswax | 28 g |
| White petrolatum | q.s. ad 100 g |
Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.
Description
Documented in sourceLight-brown ointment with a characteristic odour.
References: [1]
Use and action
Documented in sourceAEMPS records use for skin lesions, fissures, burns and wounds. This preparation is nonsterile; suitability for an individual lesion requires separate assessment.
References: [1]
Specifications
Partial evidenceLight-brown ointment with a characteristic odour. Quantities/raw-material quality follow §3. No specific numerical finished-product assay limit is provided.
References: [1]
Light
Partial evidenceProtect virgin castor oil from light.
References: [4]
Air
Partial evidenceCastor oil can undergo oxidative rancidity.
References: [4]
Water and solubility
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Humidity
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Temperature
Partial evidenceFinished-product storage: Below 30°C. Processing follows the method-specific temperatures.
References: [1]
pH and related incompatibilities
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Other incompatibilities
Not establishedNo specific finished-product information is established in the reviewed sources. Additional evidence is required before defining a specification.
References: [1]
Ingredient-specific information
Partial evidenceExact identities: Βάλσαμο Περού / Peru balsam; Παρθένο καστορέλαιο / Virgin castor oil; Λευκός κηρός μελισσών / White beeswax; Λευκή βαζελίνη / White petrolatum. Use pharmacopoeial raw materials of the referenced edition, with CoA verification. Do not arbitrarily change salt, hydration state or strength. Record the actual q.s. amount in the batch.
References: [1]
Compounding conditions
Documented in sourceLaboratory environment under the referenced AEMPS procedure: 25±5°C and relative humidity ≤60%, unless the specific formulation requires otherwise. Room temperature differs from processing temperature.
References: [2]
Personal protective equipment
Partial evidenceClean protective clothing and head covering under AEMPS PN/L/PG/002/00. Use suitable gloves where contact is possible and respiratory/eye protection where powder handling requires it. Exact glove material, ventilation and respiratory protection must follow the SDS and local exposure assessment.
References: [3]
Risks and precautions
Documented in sourcePeru balsam may cause hypersensitivity, photodermatitis and phototoxic reactions according to the source. Assess staff exposure and allergy history.
References: [1]
BUD rationale
Partial evidenceThe specific monograph states 3 months under its specified conditions. This is a source period, not independently verified stability of the local batch. Match composition, preservative, container and storage, check applicable requirements and obtain responsible approval. The actual date remains blank.
References: [1]
Bases and dependencies
Documented in sourceNo separate compound base is required in the explicit formula.
References: [1]
Equipment
Editorial checklistBalance with suitable resolution, mortar/spatula, suitable mixing vessels and final container. Add volumetric equipment for mL, a controlled water bath where melting is specified and a suitable filter where required. Analytical equipment follows the QC methods.
References: [2]
Preparation procedure
Documented in source1. Melt beeswax and petrolatum in a 50–70°C water bath.
2. Mix Peru balsam with castor oil in a mortar.
3. Add this mixture to the melted base, stirring until ambient temperature. The theoretical petrolatum quantity is 60 g before any documented batch adjustments.
Observations
Partial evidenceThe base contains 28% beeswax and differs from common softer balsam ointments. Do not change the base while retaining the same beyond-use period.
References: [1]
Packaging
Documented in sourceOpaque jar.
References: [1]
Labelling
editorial_specimenPeru balsam ointment 6% w/w
Quantity: _____ · Batch: _____ · Prepared: _____ · Use by: _____
External use only. Storage: Below 30°C.
Patient/directions or laboratory use: _____ · Pharmacy/telephone: _____
Specimen for pharmacist adaptation; not a final approved label.
References: [1]
Quality control
Partial evidenceUnder AEMPS: organoleptic properties and final mass. Batch production additionally requires spreadability PN/L/CP/003/00 and microbiological testing under RFE 5.1.4. The source does not specify a formula-specific active assay. Uniform appearance alone does not establish content uniformity.
Storage
Documented in sourceBelow 30°C.
References: [1]
Dispensing and directions
Documented in sourceThe source gives 2–3 applications/day. Avoid extensive or prolonged application. Do not use with ingredient hypersensitivity. Stop if an allergic reaction develops.
References: [1]
Sources and traceability
- FN/2006/PO/041 POMADA DE BÁLSAMO DE PERÚ
FN/2006/PO/041 · Master formula §§3–4; packaging/storage §5; description §6; period §7; use/precautions §§8–12 and patient leaflet · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- PN/L/FF/006/00 ELABORACIÓN DE POMADAS
PN/L/FF/006/00 · §4.3 environment; §4.4 method; §4.6 controls · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- PN/L/PG/002/00 INDUMENTARIA
PN/L/PG/002/00 · Clothing and protective equipment · A2 official technical guidance
Review date reported in supplied metadata: 2026-09-10
- FN/2003/PA/031 RICINO, ACEITE VIRGEN DE
FN/2003/PA/031 · Raw-material properties, handling and incompatibilities · A1 official formulary
Review date reported in supplied metadata: 2026-09-10
- AEMPS — Aviso legal
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
- BOE — Real Decreto 1495/2011, artículos 7–10 y anexo
Policy checked 2026-09-10 · Reuse conditions · Rights policy, not clinical evidence
Review date reported in supplied metadata: 2026-09-10
Provenance and reuse
Source: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Formulario Nacional. Original Greek/English rendering and restructuring: Greek Formulary Sikalias, Stasinos Chr. Sikalias, compounding.gr. Reuse basis: AEMPS legal notice and RD 1495/2011, Articles 7–10/Annex. Composition and units retained; references, distinct editorial notes and blank batch fields added. AEMPS endorsement is not implied. Edition code appears in the reference; NIPO 134-20-002-3 / 090-22-245-5. The PDFs do not state an exact internal revision date. Access checked 10 September 2026.
SHA-256 of the supplied PDF: 096e2638fca55eea97cc1f034a9e0b5512b7d038bef7efb4909a70b09810fe93